Medication info
Telmutwin Tablet 40/10 mg

Telmutwin Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
This double tablet is oval-shaped and convex on both sides, with a white and light gray color.
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201701408 · Approved 2017.03.23 · Insurance code 642306930

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, direct conversion to this medicine may be considered when blood pressure is not adequately controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 milligrams. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Patients with essential hypertension may initially attempt single therapy with either amlodipine or telmisartan for blood pressure control; however, there may be instances where blood pressure is not adequately controlled with monotherapy. In such cases, the combination of these two medications can enhance the blood pressure-lowering effect and facilitate more stable blood pressure management. Therefore, it is possible to effectively control blood pressure for essential hypertension through combination therapy with amlodipine and telmisartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, direct conversion to this medicine may be considered when blood pressure is not adequately controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 milligrams. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can pose serious risks to the fetus and newborn during pregnancy, particularly in the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. This medication is contraindicated in patients with certain conditions. For instance, individuals with allergies to this medication's components, biliary obstruction diseases, severe liver dysfunction, severe hypotension, cardiogenic shock, or unstable heart failure following acute myocardial infarction should not use it. Furthermore, patients with primary aldosteronism, aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy, liver disorders, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly should use this medication cautiously. The most common side effects when taking this medication include dizziness and peripheral edema, and serious side effects, such as fainting, may rarely occur. If side effects are experienced, medical consultation should be sought immediately. The use of this medication should be avoided during pregnancy, and if pregnancy is confirmed, discontinuation should occur as soon as possible and substituted with other safe treatments. Due to the risk of hypotension, patients with insufficient fluid or salt should correct their condition before taking this medication, and if hypotensive symptoms arise, appropriate actions should be taken. As blood potassium levels may increase, caution should be exercised when taking potassium supplements or potassium-rich foods, and regular monitoring of serum potassium and renal function is advised. Patients with compromised kidney function should frequently monitor their renal function and electrolyte levels while taking this medication. For patients with cardiovascular diseases, caution is warranted due to the potential worsening of myocardial infarction or angina from blood pressure reduction. This medication may cause drowsiness or dizziness; therefore, caution should be exercised while driving or operating hazardous machinery. There may be interactions with other medications, particularly when co-administered with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, or grapefruit juice; medical consultation should be performed in such cases. It is advisable for breastfeeding women not to take this medication. Safety and efficacy in pediatric patients have not been sufficiently established; hence, use in this population is not recommended. Although this medication can be administered to elderly patients without dosage adjustment, caution is necessary as they may respond more sensitively. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur, so immediate medical attention is required. This medication should be kept out of the reach of children and not transferred to other containers to maintain quality. It should be stored sealed until administration, and it is best to open the packaging just before taking it.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste disturbances
  • tremors
  • extrapyramidal disorders
  • muscle hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • abnormal liver function
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendinopathy
  • renal dysfunction
  • urinary disease
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • reduction in hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container that blocks light, and the storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This storage method will safely preserve the effectiveness of the medication.

Appearance and packaging

Appearance

This double tablet is oval-shaped and convex on both sides, with a white and light gray color.

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.